Actively Recruiting
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Led by Alexandria University · Updated on 2024-07-30
40
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Recently, few studies have attempted to test the regenerative effects of human insulin application by microneedling on atrophic scars versus other topical preparations. However, the scars were limited etiologically to acne scars. In addition, a lack of inclusion of a control group instead of comparing topical preparations with insulin was also a limitation to these studies. A control group consisting of microneedling alone would have served as a better comparison in order to determine whether the effects of microneedling are augmented by topical protein-rich preparations.
CONDITIONS
Official Title
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 12 to 60 years
- Atrophic scars caused by trauma or surgery
- Scars must be completely healed
You will not qualify if you...
- History or tendency of hypertrophic or keloidal scars
- Treatment received for the scar in the past 3 months
- Diabetes or history of abnormal blood sugar levels
- Pregnant or breastfeeding females
- Active infection at the scar site
- Current or recent isotretinoin treatment (within past month)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alexandria University, Faculty of Medicine
Alexandria, Egypt
Actively Recruiting
Research Team
D
Dalia I Halwag, PhD, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here